C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: The Rotterdam study

Stroke

Volumn 33, Issue 12, 2002, Pages 2750-2755

  Van der Meer, Irene M ^a,b   De Maat, Moniek P M ^b   Elisabeth Hak, A ^a   Kiliaan, Amanda J ^c   Del Sol, Antonio Iglesias ^a   Van der Kuip, Deirdre A M ^a   Nijhuis, Rogier L G ^a   Hofman, Albert ^a   Witteman, Jacqueline C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

^c NUMICO RESEARCH   (Netherlands)

Author keywords

Atherosclerosis; C reactive protein; Inflammation; Risk factors

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL;

ADULT; AORTA ATHEROSCLEROSIS; ARTERIAL TRUNK; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DISEASE COURSE; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; STROKE;

AGE DISTRIBUTION; AGED; ANKLE; AORTA, ABDOMINAL; ARM; ARTERIOSCLEROSIS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CALCINOSIS; CAROTID ARTERIES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; ILIAC ARTERY; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 0036901493     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000044168.00485.02     Document Type: Article

References (31)

1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk o f cardiovascuIar disease in apparentlyaspiin, and the isk of cardiovascular disuse in apparently healthy men. N Engl J Med. 1997;336:973-979.
2. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D'Agostino RB, Franzblau C, Wilson PW. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham study. Stroke. 2001:32:2575-2579.
3. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97:2007-2011.
4. Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 1995;73:374-379.
5. Erren M, Reinecke H, Junker R, Fobker M, Schuite H, Schurek JO, Kropf J, Kerber S, Breithardt G, Assmann G, Cullen P. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol. 1999;19:2355-2363.
6. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425-428.
7. van der Meer IM, de Maat MP, Bots ML, Breteler MM, Meijer J, Kiliaan AJ, Hofman A, Witteman JC. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: The Rotterdam Study. Arterioscler Thromb Vasc Biol. 2002;22:838-842.
8. Libby P, Ridker PM, Maseri A. Inflammation and atheroscierosis. Circulation. 2002;105:1135-1143.
9. Folsom AR, Pankow JS, Tracy RP, Arnett DK, Peacock JM, Hong Y, Djousse L, Eckfeldt JH. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol. 2001;88:112-117.
10. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365-372.
11. Zaman AG, Helft G, Worthley SG, Badimon JJ. The role of plaque rapture and thrombosis in coronary artery disease. Atherosclerosis. 2000: 149:251-266.
12. Hashimoto H, Kitagawa K, Hougaku H, Shimizu Y, Sakaguchi M, Nagai Y, Iyama S, Yamanishi H, Matsumoto M, Hori M. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation. 2001;104:63-67.
13. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 1991;7:403-422.
14. Bots ML, Hoes AW, Koudstaal PJ. Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation. 1997;96:1432-1437.
15. van Bemmel JH, Kors JA, van Herpen G. Methodology of the modular ECG analysis system MEANS. Methods Inf Med. 1990;29:346-353.
16. Witteman JC, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Hofman A. Cigarette smoking and the development and progression of aortic atherosclerosis: A 9-year population-based follow-up study in women. Circulation. 1993;88:2156-2162.
17. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arte Rioscler Thromb Vasc Biol. 1998;18:185-192.
18. Stoffers J. Kaiser V, Kester A, Schouten H, Knottnerus A. Peripheral arterial occlusive disease in general practice: The reproducibility of the ankle-arm systolic pressure ratio. Scand J Prim Health Care. 1991;9: 109-114.
19. de Maat MPM, Haverkate F, Kluft C. C-reactive protein: A cardiovascular risk factor: Report on the CRP hot-topic workshop October 1, 1997. Fibrinolysis Proteol. 1998;12:323-327.
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986:1:307-310.
21. Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: A cohort study. BMJ. 1996;313:1440-1444.
22. Wilson PW, Kauppila LI, O'Donnell CJ, Kiel DP, Hannan M, Polak JM, Cupples LA. Abdominal aortic calcific deposits are an important predictor of vascular morhidity and mortality. Circulation. 2001;103: 1529-1534.
23. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications. Clin Chem. 1997;43:52-58.
24. Oei HH, Vliegenthart R, Hak AE, Iglesias del Sol A, Hofman A, Oudkerk M, Witteman JC. The association between coronary calcification assessed by electron beam computed tomography and measures of extracoronary atherosclerosis: The Rotterdam Coronary Calcification Study. J Am Coll Cordiol. 2002;39:1745-1751.
25. Redberg RF, Rifai N, Gee L, Ridker PM. Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: Implications for coronary artery disease screening. J Am Coll Cardiol. 2000;36:39-43.
26. Doherty TM, Detrano RC, Mautner SL, Mautner GC, Shavelle RM. Coronary calcium: The good, the bad, and tile uncertain. Am Heart J. 1999;137:806-814.
27. Hyman JB, Epstein FH. A study of the correlation between roentgenographic and post-mortem calcification of the aorta. Am Heart J. 1954:48: 540-543.
28. Abbott RD, Curb JD, Rodriguez BL, Masaki KH, Yano K, Schatz IJ, Ross GW, Petrovitch H. Age-related changes in risk factor effects on the incidence of coronary heart disease. Ann Epidemiol. 2002;12:173-181.
29. Lakka TA, Salonen R, Kaplan GA, Salonen JT. Blood pressure and the progression of carotid atherosclerosis in middle-aged men. Hypertension 1999;34:51-56.
30. Rifai N, Ridker PM. Proposed cardiovascular risk assessment algorithm using high sensitivity C-reactive protein and lipid screening. Clin Chem. 2001:47:28-30.
31. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM Jr. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 2001;344:1959-1965.